0001237899-19-000024.txt : 20191126
0001237899-19-000024.hdr.sgml : 20191126
20191126160228
ACCESSION NUMBER: 0001237899-19-000024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191122
FILED AS OF DATE: 20191126
DATE AS OF CHANGE: 20191126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VAGELOS P ROY
CENTRAL INDEX KEY: 0001013064
STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721]
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 191250824
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2019-11-22
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001013064
VAGELOS P ROY
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
Chairman of the Board
Common Stock
2019-11-14
5
G
0
40681
0.0
D
347824
D
Common Stock
2019-11-21
5
G
0
7246
0.0
D
340578
D
Common Stock
2019-11-22
4
M
0
46138
21.25
A
386716
D
Common Stock
2019-11-22
4
F
0
23989
358.33
D
362727
D
Common Stock
2019-11-22
5
G
0
14000
0.0
D
348727
D
Common Stock
2019-11-25
5
G
0
22093
0.0
D
326634
D
Common Stock
2019-11-25
4
S
0
156
358.92
D
326478
D
Common Stock
2019-11-25
4
S
0
1479
359.46
D
324999
D
Common Stock
2019-11-25
4
S
0
592
360.37
D
324407
D
Common Stock
2019-11-25
4
S
0
2492
361.46
D
321915
D
Common Stock
2019-11-25
4
S
0
2284
362.61
D
319631
D
Common Stock
2019-11-25
4
S
0
3605
363.53
D
316026
D
Common Stock
2019-11-25
4
S
0
3755
364.55
D
312271
D
Common Stock
2019-11-25
4
S
0
3269
365.25
D
309002
D
Common Stock
2019-11-25
4
S
0
4517
366.63
D
304485
D
Common Stock
2019-07-02
5
G
0
669
0.0
D
145661
I
by CLAT
Common Stock
2019-10-02
5
G
0
764
0.0
D
144897
I
by CLAT
Common Stock
2326
I
By 401(k) Plan
Common Stock
83652
I
by Spouse as Trustee
Common Stock
1203
I
by trust for grandch
Non-Qualified Stock Option (right to buy)
21.25
2019-11-22
4
M
0
46138
0.0
D
2019-12-18
Common Stock
46138
107655
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 156 shares of Company stock on November 25, 2019 at prices ranging from $358.68 to $358.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
Represents volume-weighted average price of sales of 1,479 shares of Company stock on November 25, 2019 at prices ranging from $359.05 to $359.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
Represents volume-weighted average price of sales of 592 shares of Company stock on November 25, 2019 at prices ranging from $360.01 to $360.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
Represents volume-weighted average price of sales of 2,492 shares of Company stock on November 25, 2019 at prices ranging from $361.06 to $361.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
Represents volume-weighted average price of sales of 2,284 shares of Company stock on November 25, 2019 at prices ranging from $362.02 to $362.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
Represents volume-weighted average price of sales of 3,605 shares of Company stock on November 25, 2019 at prices ranging from $363.00 to $363.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
Represents volume-weighted average price of sales of 3,755 shares of Company stock on November 25, 2019 at prices ranging from $364.04 to $364.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
Represents volume-weighted average price of sales of 3,269 shares of Company stock on November 25, 2019 at prices ranging from $365.02 to $365.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
Represents volume-weighted average price of sales of 4,517 shares of Company stock on November 25, 2019 at prices ranging from $366.07 to $366.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price.
By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
/s/**P. Roy Vagelos
2019-11-26